Dissertation > Excellent graduate degree dissertation topics show

α-Lipoid Acid Prevents Endothelial Dysfunction in HUVEC-12 Via Up-regulation of Lysyl Oxidase

Author: RongJiDong
Tutor: ZhangShuYing
School: Zunyi Medical College,
Course: Internal Medicine
Keywords: lysyl oxidase homocysteine α-lipoid acid matrix metalloproteinase-2 endothelial function
CLC: R543.5
Type: Master's thesis
Year: 2011
Downloads: 0
Quote: 0
Read: Download Dissertation

Abstract


Objective:To examine the effect ofα-lipoid acid (ALA) on the expression of lysyl oxidase (LOX) and MMP-9 in human umbilical vein endothelial cells (HUVECs), and to investigate the possible mechanism of endothelial injury induced by homocysteine.Methods:1. HUVECs were cultured in vitro.2. Culture the HUVECs with medium containing the different concentrations of Hey, ALA for 24h, Survival of HUVECs were tested by MTT assay.3. ROS activity was assessed by a highly sensitive fluorescent assay.4. Total RNA was isolated and performed RT-PCR. Then photograph and analyze the band. Compare the LOX, MMP-2 toβ-actin for half-quantitative analysis.5. Total protein was isolated and performed Western blot. Compare the LOX toβ-actin for quantitative analysis.Results:1. Hey can inhibit the survival of HUVECs, and the effect is concentration-dependent after 24h incubation(p<0.01). Among the ALA groups of different concentrations, there was a significant increase (P<0.01 at 0.5mmol/L and 1.0mmol/L).2. Incubation of HUVECs with increasing concentrations of Hey resulted in a dose-dependent and significant increase in intracellular fluorescence intensity which meant an increased generation of ROS. While pre-incubated with Hey before ALA significantly reversed its effect on endothelial ROS generation (P<0.05).3. mRNA levels of LOX were down-regulated by Hey treatment in endothelial cells in a dose-dependent manner(P<0.01). The addition of MMP-9 expression was associated with a decrease in LOX expression. Inhibition of LOX activity either by Hey or by BAPN, the inhibitor of LOX, increased endothelial MMP-9 expression (P<0.01 at 0.05mmol/L). Western blot results suggest that Hey may down-regulate LOX expression in endothelial cells in a dose-dependent manner(P<0.01).4. ALA may up-regulate LOX expression, down-regulate MMP-2 expression in endot-helial cells after Hey treatment. The reduction of MMP-9 expression was associated with an increase in LOX expression. RT-PCR results suggest that pre-incubated with Hey before ALA significantly increased LOX mRNA expression and down-regulate MMP-2 expression. Western blot results suggest that pretreated with Hey before ALA markedly ameliorated the effect of Hey on LOX expression (P<0.01).Conclusion:1. ALA has protective effects on endothelial cells.2. Hey can increase ROS generation which leads to endothelial dysfunction. ALA can protect the vascular endothelium against the injury induced by Hey, keeping the HUVECs away from oxidative injury.3. Hey can decrease the level of LOX mRNA and up-regulate MMP-2 mRNA expres-sion in HUVECs. The results suggest that LOX inhibition in contributes to the endothelial dysfunction associated with hyperhomocysteinemia.4. Endothelial dysfunction induced by Hey is associated with a decrease of LOX expr-ession. ALA can increase the level of LOX mRNA and down-regulate MMP-2 mRNA expression in HUVECs. The results suggest that up-regulation the expression of LOX by ALA can contribute to the vascular beneficial actions of this drug and to the cardiovascular risk reduction achieved by this therapy.

Related Dissertations

  1. Cloning and Expression Analysis of GPx, GST and SAHH Genes in Chlamydomonas Sp. ICE-L from Antarctica,Q943.2
  2. C-reactive protein,homocysteine ??levels in type 2 diabetic peripheral neuropathy of TCM,R259
  3. Roles of MMP-7 and Lysozyme in the Pathogenesis of Ulcerative Colitis Induced by DSS in Balb/c Mice,S858.91
  4. Common TCM syndrome and serum homocysteine ??and diastolic function relationships of the newly diagnosed patients with type 2 diabetes,R259
  5. The Relationship of Polymorphisms of Methionine Synthase Reductase(MTRR) Gene and Plasma Homocysteine Levels with Myocardial Infarction,R542.22
  6. The Expression of MMP-2、 VEGF and Ki-67 and Human Glioma Grade,R739.41
  7. Study on the Expression and Correlation of Metallothionein and Matrix Metalloproteinase-2 in Non-small Cell Lung Cancer,R734.2
  8. Effects of the Applied External Weak Steady Direct Current Electrical Fields on Diastolic Function after Balloon Injury in the Rabbit Abdominal Aorta,R541.4
  9. Effect of Acupuncture and Minimally Invasive Hematoma Aspiration on Rabbit Brain Damnification in Acute Stage of Intracerebral Hemorrhage,R245
  10. Studies on the Growth and Transfer Behaviour of Hca-F Cell and Immunomodulatory of fucoidan,R285.5
  11. Ultrasonic Cardiogram Study on the Changes of Left Ventricular Function and Vascular Endothelial Function in Uremia Patients with Different Blood Pressure Levels,R445.1
  12. Effect of Etiasa on the Expression of MMP-2 and TNF-α in Rat Model of Ulcerative Colitis,R574.62
  13. Fucosylation Influences Extracellular Matrix Accumulation in Tgf-β-stimulated Hk-2 Cells,R692
  14. The Clinical Study on Relationship between Plasma Homocysteine Levels and Recurrent Cerebral Infarction,R743.3
  15. Retinoic acid and matrine intervention rat hepatoma change process β-catenin, E-cadherin, MMP-7 dynamic changes,R735.7
  16. Analysis on Effects of Expression of MMPs and ECM by Hormonal and Correlation of β1,4-GalTⅠ,R363
  17. Meningiomas and MMP-9, VEGF expression and tumor angiogenesis and recurrence,R739.45
  18. Efects of Obesity on Insulin Resistance, Endothelial Function and β Cell Function,R587.1
  19. The Effect of Ang(1-7)/MAS Pathway on Pancreatic Islet Microcirculation and Function in Rat with Long-term High-fat Diet,R587.1
  20. Ang(1-7) Improves Pancreatic Islets Function Via Upregulation of eNOS Expression in Rats with High-fat Diet,R587.1

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Vascular disease > Artery disease
© 2012 www.DissertationTopic.Net  Mobile